Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide Effect on Enteral Lipid Release
NCT03442972Phase 3Completed
- Sponsor
- University Health Network
- Start
- Jan 2019
- Primary completion
- Jun 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in hyperlipidemia, sponsored by University Health Network. Started Jan 2019; status: completed.
02
Drugs
teduglutide
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT03442972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03442972.